Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Study Comparing EG-1962 to Standard of Care Oral Nimodipine in Adults With Aneurysmal Subarachnoid Hemorrhage
Phase of Trial: Phase III
Latest Information Update: 27 Jun 2018
At a glance
- Drugs Nimodipine (Primary) ; Nimodipine
- Indications Cerebral ischaemia; Subarachnoid haemorrhage
- Focus Registrational; Therapeutic Use
- Acronyms NEWTON 2
- Sponsors Edge Therapeutics
- 27 Jun 2018 According to the Edge Therapeutics media release, company expects to report the final analysis data from all 283 subjects from this study when the data are available later this year.
- 27 Jun 2018 Results presented in the Edge Therapeutics media release.
- 10 Apr 2018 This trial is completed in Germany.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History